SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001102624-15-001644
Filing Date
2015-11-09
Accepted
2015-11-09 16:10:14
Documents
2
Period of Report
2015-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 THERAVANCE BIOPHARMA, INC. 8-K theravancebio8k.htm 8-K 4949
2 THERAVANCE BIOPHARMA, INC. PRESS RELEASE theravancebiopharmainc.htm EX-99 21153
  Complete submission text file 0001102624-15-001644.txt   27262
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36033 | Film No.: 151215680
SIC: 2834 Pharmaceutical Preparations